- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
Patent holdings for IPC class A61K 38/33
Total number of patents in this class: 85
10-year publication summary
|
5
|
3
|
5
|
7
|
2
|
6
|
4
|
2
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
22 |
| Ipsen Pharma S.A.S. | 387 |
13 |
| Aimsco Limited | 14 |
3 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 807 |
3 |
| NED Biosystems, Inc. | 11 |
3 |
| Trustees of Tufts College | 826 |
3 |
| Tufts Medical Center, Inc. | 225 |
3 |
| Aequus Biopharma, Inc. | 3 |
2 |
| Palatin Technologies, Inc. | 75 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4019 |
2 |
| Serina Therapeutics, Inc. | 42 |
2 |
| University of Cincinnati | 835 |
2 |
| Centre National de La Recherche Scientifique | 10140 |
1 |
| The Regents of the University of Michigan | 4595 |
1 |
| Centre hospitalier universitaire de Rouen | 55 |
1 |
| Galderma Research & Development | 416 |
1 |
| Louisiana State University | 2 |
1 |
| Medizinische Universitat Wien | 189 |
1 |
| Menarini International Operations Luxembourg S.A. | 94 |
1 |
| Orbis Health Solutions LLC | 37 |
1 |
| Other owners | 17 |